SARS-CoV-2 variants implications for immunity and vaccine development /

Viečča ollesdeavstta
Series

SARS-COV-2 human monoclonal antibody therapy update

Viečča ollesdeavstta
Series

Impact of COVID-19 on neuropsychiatric disorder and mental health

Viečča ollesdeavstta
Series

Comparison of COVID-19 and seasonal HCoV pathologies and transfer to endemic state

Viečča ollesdeavstta
Series

The impact of asymptomatic infections the Italian municipality of Vo' as a case study /

Viečča ollesdeavstta
Series

COVID-19 epidemiology and variants new challenges and future of the pandemic /

Viečča ollesdeavstta
Series

SARS-CoV-2 mutations phenotypes and implications for vaccine development /

Viečča ollesdeavstta
Series

Triage and end of life care planning in COVID-19

Viečča ollesdeavstta
Series

Potential long-term health effects of a SARS-CoV-2 infection

Viečča ollesdeavstta
Series

The COVID-19 coronavirus outbreak October 2020 update /

Viečča ollesdeavstta
Series

Presence and function of SARS-CoV-2-specific T-cells in recovered patients and healthy volunteers

Viečča ollesdeavstta
Series

Rheumatic diseases and COVID-19

Viečča ollesdeavstta
Series

The cardiovascular complications of SARS-CoV-2 infection

Viečča ollesdeavstta
Series

The COVID-19 coronavirus outbreak May 2020 update /

Viečča ollesdeavstta
Series

Strategies for exiting the lockdown

Viečča ollesdeavstta
Series

COVID-19 epidemiology and potential treatments follow up interview /

Viečča ollesdeavstta
Series

The COVID-19 coronavirus outbreak March 2020 update /

Viečča ollesdeavstta
Series

The COVID-19 outbreak an update on the SARS-CoV-2 virus /

Viečča ollesdeavstta
Series

The COVID-19 coronavirus outbreak a current view /

Viečča ollesdeavstta
Series